PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION.pdf

PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION Chapter 31 - Thyroid and Antithyroid Drugs 161 Chapter 1 - The Nursing Process and Drug Therapy 3 Chapter 2 - Pharmacologic Principles 7 Chapter 3 - Lifespan Considerations 13 Chapter 4 - Cultural Legal and Ethical Considerations 19 Chapter 5 - Medication Errors Preventing and Responding 25 Chapter 6 - Patient Education and Drug Therapy 29 34 Chapter 7 - Over -the-Counter Drugs and Herbal and Dietary Supplements Chapter 8 - Gene Therapy and Pharmacogenomics 38 Chapter 9 - Photo Atlas of Drug Administration 42 Chapter 10 - Analgesic Drugs 50 Chapter 11 - General and Local Anesthetics 57 Chapter 12 - Central Nervous System Depressants and Muscle Relaxants 61 Chapter 13 - Central Nervous System Stimulants and Related Drugs 66 Chapter 14 - Antiepileptic Drugs 70 Chapter 15 - Anti-Parkinson Drugs 75 Chapter 16 - Psychotherapeutic Drugs 80 Chapter 17 - Substance Use Disorder 87 Chapter 18 - Adrenergic Drugs 92 Chapter 19 - Adrenergic -Blocking Drugs 97 Chapter 20 - Cholinergic Drugs 102 Chapter 21 - Cholinergic -Blocking Drugs 107 Chapter 22 - Antihypertensive Drugs 112 Chapter 23 - Antianginal Drugs 118 Chapter 24 - Heart Failure Drugs 124 Chapter 25 - Antidysrhythmic Drugs 129 Chapter 26 - Coagulation Modifier Drugs 134 Chapter 27 - Antilipemic Drugs 140 Chapter 28 - Diuretic Drugs 145 Chapter 29 - Fluids and Electrolytes 151 Chapter 30 - Pituitary Drugs 157 Chapter 32 - Antidiabetic Drugs 166 Chapter 33 - Adrenal Drugs 174 Chapter 34 - Women’s Health Drugs 178 Chapter 35 - Men’s Health Drugs 185 Chapter 36 - Antihistamines Decongestants Antitussives and Expectorants 189 Chapter 37 - Respiratory Drugs 194 Chapter 38 - Antibiotics Part 1 199 Chapter 39 - Antibiotics Part 2 206 Chapter 40 - Antiviral Drugs 211 Chapter 41 - Antitubercular Drugs 216 Chapter 42 - Antifungal Drugs 221 Chapter 43 - Antimalarial Antiprotozoal and Anthelmintic Drugs 226 Chapter 44 - Anti-inflammatory and Antigout Drugs 231 Chapter 45 - Antineoplastic Drugs Part 1 Cancer Overview and Cell Cycle 236 Chapter 46 - Antineoplastic Drugs Part 2 Cell Cycle Nonspecific and Misc. Chapter 01: The Nursing Process and Drug Therapy Lilley: Pharmacology and the Nursing Process, 9th Edition MULTIPLE CHOICE 1. The nurse is developing a human needs statement for a patient who has a new diagnosis of heart failure. Identification of human needs statements occur with which of these activitie s? a. Collection of patient data b. Administering interventions c. Deciding on patient outcomes d. Documenting the patient’s behavior ANS: A Identification of human needs occurs with the collection of patient data. DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Human Needs Statement MSC: NCLEX: Safe and Effective Care Environment: Management of Care 2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and gave the medication 2 hours after the schedu led dose was due. What type of problem does this represent? a. “Right time” b. “Right dose” c. “Right route” d. “Right medication” ANS: A “Right time” is correct because the medication was given more than 30 minutes after the scheduled dose was due. “Dose” is incorrect because the dose is not related to the time the Drugs 242 Chapter 47 - Biologic Response –Modifying and Antirheumatic Drugs 247 Chapter 48 - Immunosuppressant Drugs 252 Chapter 49 - Immunizing Drugs 257 Chapter 50 - Acid-Controlling Drugs 262 Chapter 51 - Bowel Disorder Drugs 268 Chapter 52 - Antiemetic and Antinausea Drugs 275 Chapter 53 - Vitamins and Minerals 280 Chapter 54 - Anemia Drugs 286 Chapter 55 - Nutritional Supplements 292 Chapter 56 - Drugs 296 Chapter 57 - Ophthalmic Drugs 302 Chapter 58 - Otic Drugs 307